We previously demonstrated that selective knockout of transient receptor potential ankyrin 1 (TRPA1) cation channels from vascular endothelial cells exacerbated neuronal damage following ischemic stroke, and treatment with a TRPA1 agonist improved outcomes (Pires and Earley, 2018). This evidence concerns the gene TRPA1 and ischemic stroke.